Protagen announced new members to its supervisory board. Dirk Ehlers, CEO of Trumpf Medical, was elected to Protagen's board, while Ulrich Kintzel, senior investment manager of NRW.Bank, and Matthias Guth of MIG have joined the board succeeding colleagues from their respective firms.
Elhers has held executive positions at Eppendorf, Roche Diagnostics, Evotec, Fresenius Kabi, and Olympus Diagnostics. Kintzel succeeds Aristotelis Nastos as the board representative from NRW.Bank. Guth follows Michael Motschmann as the board representative from MIG.